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Abstract
In recent time, the therapeutic use of medicinal plants has increased all over 
the world. The efficacy of herbs for curative purposes is often accounted of its 
mineral and organic constituents. Neutron activation analysis (INAA) has been 
applied to mineral determination of Aristolochia Longa (bereztem), medicinal 
plant used to cure some diseases observed in Algeria especially cancer. In this 
work the mass fractions of Cr (15.22 ± 3.5 μg/g), Na (269.98 ± 25.01 μg/g), La 
(0.478 ± 0.041 μg/g), K (1.33 ± 0.23 μg/g), Br (1.2 ± 0.19 μg/g), As (0.697 ± 0.038) 
and Sb (66.09 ± 11.24 μg/g), were determined. This herb was collected from 
Taourirt Aden Berber village situated in Northern Algeria. Five elements were 
quantified in certified AIEA standards IAEA-V10 and IAEA-SL1 for checking the 
accuracy of our procedure. It was noteworthy the values obtained from this work 
are in good agreement with the certified values, the Z-score values for all elements 
were |Z| < 3. We believe that herb is natural and harmless compared with chemical 
drugs. Unfortunately the potential toxicity due to the Aristolochia Acids content has 
required the analysis of Aristolochia Longa by CG/MS and HPLC to highlight this 
compound. The standard of Aristolochic Acid (Sigma A5512-25 mg Yellow powder 
lot # wxbb6331VPCODE) was used as reference.
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1. Introduction
Bereztem is the common name of Aristolochia Longa, this herb with a delicate 
aromatic odor is wrongly used as medicinal plant in Algeria [1, 2] and other coun-
tries. We find these plants in the temperate and tropical regions [3]. Since antiquity 
various Aristolochia and Asarum species have been used in herbal medicines in 
obstetrics and in treatment of Intestinal affections, coetaneous diseases, wounds, 
heart palpitation or snakebite, festering wounds, and tumors [4, 5], indeed 60% of 
drugs approved for cancer treatment are of natural origin [6, 7]. B. Benarba report 
the cytotoxic and apoptogenic activities of an aqueous extract of A. longa in the 
Burkitt’s lymphoma BL41 cell line [8]. Considered also as antidote against some 
poisonings [9]. It was reported [10, 12] that plants remain in use today especially 
in the Chinese medicine. All parts of the plant are used in herbal preparations, and 
aristolochic acids are present in the roots, stems, leaves, and fruit [11, 12]. Exposure 
to this acid could potentially occur through the ingestion or skin contact to treat 
wounds, note no published studies of skin absorption of aristolochic acids in 
humans or experimental animals were found. However certain plant as canadense 
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leaves cause the dermatitis [13]. The dried rhizome of Aristolochia Longa is the 
one of the part frequently used often without other ingredients. Several reports 
indicate the use of complementary and alternative medicine (CAM) and a lot of 
people in Algeria believe that herb is natural and harmless compared with chemi-
cal drugs. Unfortunately, they are unaware of its adverse biological effects. The 
Aristolochic Acids content, alkaloid components are known to be mutagenic and 
carcinogenic [14]. The clinical syndrome to the Chinese plants Nephropathy (NCP) 
was reported in first in Belgium for the women having followed a Chinese slim-
ming diet in 1992 after consumption of herbal weight loss preparations containing 
Aristolochia Fangehi by inadvertence instead Stephania Tetrandra [15]. Kupchan 
and Doskovitch 1962 [16], have tested the antitumor effects of aristolochic acids in 
mice and in clinical trials. But when Jackson et al. [17] showed the neph-rotoxicity 
of aristolochic acid the trials were discontinued. Mix et al. [18]; Kumar et al. [19] 
Described twelve Aristolochic Acid analogues, the major compounds of AAS 
include AAI and its demethoxylates derivative, AAII, generally the levels of AAI are 
higher than AAII, the Figure 1 shown their structures. The metabolites are excreted 
in the urine and the feces. Reported half-lives in New Zealand White rabbits for 
aristolochic acids I and II were 0.12 hours and 0.27 hours, respectively. Studies in 
rats show that the metabolites of aristolochic acid I are excreted within 24 hours, 
whereas metabolites of aristolochic acid II are still present in the urine at 72 hours. 
Furthermore the curative properties of this plant are based only on traditional 
knowledge and in our country there are no procedures and regulations applicable 
about the use and marketing to the healing plants. Regrettably Aristolochia Longa 
is easily obtained from local markets. Unlike this herb is forbidden in several coun-
tries USA [20], Canada, Taiwan, France, and Belgium. The European Commission 
(EC) (2000) has prohibited aristolochic acid and its salts, as well as Aristolochia 
species, and their preparations in cosmetic products. The trace element present in 
Aristolochia longa L. rhizomes; determined by Neutron activation analysis (INAA) 
can may be explain some therapeutic activities. At the same time two (02) methods 
have been used for the identification of aristololochic acids (AAS). We made Gas 
chromatography – Mass spectrometry (CG/MS) and High performance Liquid 
chromatography (HPLC). This work can constitute a position paper to better use of 
this natural product by the cancer patients who take this herb.
AAs I (AAI) and II (AAII) (EMEA 2000).
Figure 1. 
Chemical structure of nitrophenanthrene carboxylic acids.
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2. Experimental
In order to analyze Aristolochia longa L., Rhizomes were collected in May 2016 
from Taourirt Aden, Algerian village situated in Kabylia region at 120 km south 
of Algiers city, Algeria. The vegetal material was washed extensively in distillated 
water as to remove superficial dust. And then dried at room temperature for one 
week-end. The dry and hard form of these roots was ground in an electric labora-
tory blender. One part of the fine powder obtained was prepared for neutron 
Activation Analysis. The triplicate samples were packed in polyethylene thin 
target and irradiated during four hours (04) in NUR Algerian reactor, 1 MW 
research reactor. After 04 and 08 days of delay time the acquisitions were done 
for determination of Cr, Na, La, K, Br, As and Sb. The analysis was done using 
HpGe – Canberra detector and the elemental concentrations were performed by 
Calcon software. The count time was twenty (20) hours for medicinal plants and 
about five (05) hours for the standards. The certified reference material SDM-2TM 
Lake (sediment marine lyophilized) was used for calibration. The quality control 
was done using IAEA biological material V10 (hay powder) and AIEA non biologi-
cal material SL-1 (lake sediment). Another part of this powder herb was used for 
the identification of Aristolochic Acids by CG/MS; and HPLC techniques. Many 
extracted methods have been reported in literature [21]. The extract of AA was 
prepared by adding 10 ml of methanol to 10 g of A. longa dry rhizomes powder 
for the first extraction and 20 ml of light petroleum for the second extraction, 
solvent extraction the most commonly used for extraction of AAs [22]. After 24 h 
of maceration under magnetic stirring at room temperature, the mixture was 
centrifuged, filtered and then concentrated in a rotary vacuum evaporator (The 
number of siphon age is ten) indeed the quantification of AA in extract products is 
less complicated as compared to herbal preparations. However to avoid the loss of 
chemical information’s the extraction method should be no selective to explain the 
therapeutic aspect. The extracted material was analyzed by CG/MS and HPLC in 
order to detect the potential presence of AAs in Aristolochia Longa. The standard 
of Aristolochic Acid recently acquired (Sigma A5512–25 mg Yellow powder lot # 
wxbb6331VPCODE.) was used as reference. It should be noted that the Aristolochic 
acids compounds are produced commercially only as reference standards and as 
research chemicals [12, 23].
3. Results and discussion
Table 1 show the Algerian medicinal plant studied with the botanical name, 
common name and the part used for treatment. Five elements were quantified in 
certified AIEA standards IAEA-V10 and IAEA-SL1 for checking the accuracy of our 
procedure. The values obtained were showed in Table 2 with the reported certified 
values. It was noteworthy the values obtained from this work are in good agreement 
with the certified values; The Figure 2 presents graphically the plot of Z-score for 
our elements.
Common name Botanical name Family Part used for treatments
Berztem Aristoloshia Longa Aristolochiaceae Root, aerial part
Table 1. 
Botanical name and parts used of the medicinal plant studied.
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Figure 2. 
Z-score values for the elements determined in IAEA standards V10 and SL1.
Table 3 report the elemental concentrations obtained from this work and shows 
the usefulness of using INAA for the elemental determination, the La, K, Br, As are 
present at trace levels and the Cr, Sb was found at minor level and Na at the major 
level. Owing to its high toxicity, the identification of AAs is obviously important 
indeed these acids cause Aristolochic Acids Nephropathy (NAA), the chronic renal 
failure according to Grollman et al. [24] and urotherial carcinomas [25, 26].
A new American study reveals that these AAs are more carcinogen than the 
tobacco [27]. The toxicity of the aristolochic acids has been studied and reported by 
Mengs and Stotzem [28]. When The Arirstolochic Acids extracted from a medicinal 
plant are traditionally used in China to cure some diseases, the arthritis and the 
other inflammations. It has been shown by various authors that these Aristolochic 
acids have directly toxic on the human gene TP53 (gene suppressor of cancer) 
[29]. No mutations were identified in rats with chronic renal failure not exposed 
to aristolochic acids. Similar findings have been reported in humans [30]. The 
complexity of herbal nomenclature systems used in traditional Chinese medicines 
may have contributed to the potential exposure to aristolochic acids. As well as the 
Element IAEA-V10 IAEA-SL1
Measured Reported Measured Reported
K* 24.65 ± 2.96 21 ± 2
Cr 6.42 ± 0.798 6.5 ± 0.75 94.92 ± 8.54 104 ± 9
Na* 0.692 ± 0.064 0.5 ± 0.3
Br 10.82 ± 1.73 8 ± 2 6.82 ± 1.73 9.79 ± 1.58
Sb
*Values given in mg/g.
Table 2. 
Quality Control assessment results (μg/g) for the AIEA - certified reference material Samples.
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similarity of the Chinese names for Aristolochia species and other innocuous herbs 
can increase risk of inadvertent exposures to aristolochic acids [31].
Even more similar Japanese and Chinese names refer to different plants in Japan 
and China [32], explained the outbreak of Chinese herb nephropathy in Japan by 
the substitution of that plant species in Japanese preparations of Chinese herbal 
medicines. In this study we are analysed the rhizome of Aristolochia Longa to 
identify the aristolochic acid much to our surprise this organic compound is not 
reveled in our herb. The Figures 3 and 4 shows the results obtained by CG/MS 
and HPLC, the characteristic retention times of AAI Acid present in our refer-











Elemental Concentrations (μg/g) for Aristoloshia Longa rhizome.
Figure 3. 
CG/MS spectrum analysis of our herb (rhizome) and (AAI) standard. (Sigma A5512–25 mg Yellow powder lot 
# wxbb6331VPCODE)
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Figure 4. 
HPLC spectrum analysis of bereztem roots and (AAI) standard. (Sigma A5512–25 mg Yellow powder lot # 
wxbb6331VPCODE)
The Aristolochic acids content of plants varies depending for the same plant 
species, where it was grown, the time of year, and other factors, that might explain 
our results? The sample matrix components can influence the limits of detection 
for Aristolochic acids. We suggested also the insufficient amount of our plant we 
used 10 mg fine powder of bereztem roots. Although the protocol experimental 
described by Cherif H.S., and all has been reproduced, in our work, these authors 
identified the Aristolochic acid (AAI) in the rhizome of bereztem collected in the 
other city of Algeria: Blida (smell city) located about 47 km in southwest of Algiers. 
While our plant is collected in the region of Taourirt Aden in (kabylia). Broad range 
of biological activity of AAs, beneficial as well as adverse effects was reported by 
Kupchan and Doskotch [33]; therefore it would be interesting to determine the 
organic composition, it is known that the essential oils contained in the rhizome 
and aerial part of this herb are mainly responsible for the antimicrobial and cyto-
toxic effect [34]. And then instead to banned the use of herbal remedy containing 
acid aristolochic it will be possible to separate the useful from the toxic fractions 
of plant.
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4. Conclusion
Seven elements have been determined in Aristiolochia Longa. L using INAA, 
technique usually quite for herbs analyses. This plant can be considered as source of 
trace elements for people who use it. However the traditional healers recommended 
the use it with care and always for short treatment periods [35]. It is clear that 
further experiences are planned to confirm or refute our results obtained by CG/
MS and HPLC for the identification of AAs. In its warning, the FDA recommended 
that all botanical remedies known or suspected of containing Aristolochic acids 
be discarded. People should be largely aware of the regulated of some botanical 
products as dietary supplements by the FDA under the Dietary Supplement Health 
and Education Act (DSHEA) of 1994 (FDA 1995) [36].
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